|
HS Code |
156478 |
| Chemical Name | N'-Methyl-L-Histidine Methyl Ester |
| Molecular Formula | C8H13N3O2 |
| Molecular Weight | 183.21 g/mol |
| Appearance | White to off-white solid |
| Cas Number | 13447-57-7 |
| Solubility | Soluble in water |
| Purity | Typically ≥98% |
| Storage Temperature | 2-8°C |
| Smiles | COC(=O)[C@@H](CN1C=NC=C1C)N |
| Inchikey | BMBGZGWDUSXLOM-UHFFFAOYSA-N |
As an accredited N'-Methyl-L-Histidine Methyl Ester factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | N'-Methyl-L-Histidine Methyl Ester is supplied in a 500 mg amber glass vial, sealed and labeled with safety and product information. |
| Shipping | N'-Methyl-L-Histidine Methyl Ester is shipped in secure, airtight containers under ambient conditions to protect it from moisture and contamination. It is labeled according to regulatory requirements and accompanied by appropriate safety documentation. For larger quantities, additional precautions such as insulated packaging or secondary containment may be used as necessary. |
| Storage | N'-Methyl-L-Histidine Methyl Ester should be stored in a tightly sealed container, protected from light and moisture. It should be kept in a cool, dry place, ideally at 2–8°C (refrigerator temperature). Ensure good ventilation in the storage area and avoid sources of heat and incompatible substances. Properly label the container and follow all relevant safety and handling guidelines. |
Applications of N'-Methyl-L-Histidine Methyl Ester in Industrial ManufacturingN'-Methyl-L-Histidine Methyl Ester is a specialty amino acid derivative with multifaceted utility in advanced pharmaceutical synthesis, peptide chemistry, veterinary feed production, and biochemical research reagent manufacturing. As an original manufacturer, we tailor our product quality to ensure regulatory compliance, formulation consistency, and process efficiency for downstream partners across these focused application fields. 1. Peptide Active Pharmaceutical Ingredient (API) SynthesisLeading peptide drug manufacturers incorporate N'-Methyl-L-Histidine Methyl Ester as a protected histidine building block in the stepwise solid-phase peptide synthesis (SPPS) of targeted APIs, including next-generation peptide hormones, enzyme inhibitors, and synthetic analogues for rare disease therapies. Its chemical structure supports selective side-chain modifications, which help scientists fine-tune peptide pharmacodynamics and metabolic stability. Quality requirements in this domain align with ICH and pharmacopeial norms, demanding high purity, traceability, and batch reproducibility. The compound enters the process during the peptide chain elongation phase, where its protected form ensures site-specific incorporation and deprotection consistency before final peptide cleavage and purification. End products typically include clinical-grade injectable peptide drugs and preclinical candidates for regulatory evaluation. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Biochemical Assay Reagent ManufacturingProducers of analytical and diagnostic kits use N'-Methyl-L-Histidine Methyl Ester as a defined substrate, control, or labeling intermediate in high-precision enzyme activity assays and affinity binding studies. The methylation and esterification protect the imidazole side chain, ensuring selectivity in downstream conjugation or detection reactions. Assay reagent manufacturing requires traceable input chemicals meeting ISO 13485 and labeling accuracy for diagnostic applications. The material generally enters during the preparation of substrate solutions or as a component of calibration mixtures. Manufacturers formulate ready-to-use assay kits and certified reference standards for pharmaceutical R&D, clinical testing, and biochemical research laboratories. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Veterinary Feed Additive PremixesMajor animal nutrition producers utilize N'-Methyl-L-Histidine Methyl Ester to fortify specialized feed premixes and supplements, especially for high-performance aquaculture, poultry, and livestock. Its inclusion helps tailor the amino acid profile, optimizing animal growth, feed utilization, and minimizing metabolic stress. Downstream premix manufacturing references regulatory frameworks covering animal-sourced feed additives, with precise dosing based on protein targets and species. The material blends into premix formulations after bulk micronization and homogeneity testing, undergoing pelleting or encapsulation for inclusion in compound feeds. Finished goods target the commercial feed and aquaculture market, particularly where fine-tuned amino acid balance is essential for growth-stage diets or stress response in intensive production environments. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Custom Biopolymer and Peptide Material R&DResearch-driven manufacturers deploy N'-Methyl-L-Histidine Methyl Ester as a functional monomer in the synthesis of tailor-made peptide-based hydrogels, smart biopolymers, and controlled-release carrier materials. Its specific N-methyl modification enables unique backbone structures and mechanical properties, impacting crosslinking density and degradation rates in biomedical or materials science applications. Downstream integration occurs during solvent-phase polymerization or peptide hydrogelation steps, with dosage levels determined by the targeted material attributes and application field (e.g., slow-release devices, biosensors). Regulatory requirements reflect both chemical safety and device application, with R&D-grade production typically used in preclinical or prototype-stage goods that later transition to formal quality validation. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive N'-Methyl-L-Histidine Methyl Ester prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Every chemical tells the story of the work behind it. In the case of N-Methyl-L-Histidine Methyl Ester—model number NMHE-2172—the process starts with a deep understanding of the nature of histidine itself. Anyone synthesizing such a precise derivative knows that quality relies on more than clean equipment or certified feedstock; it depends on an informed approach to each small adjustment along the synthesis pathway. Working with this compound means working with the nuances of methyl groups, the selectivity of N-methylation, the challenge of esterification without unwanted byproducts, and the attention paid to moisture and pH every step along the way.
Over the years, consistent conversations with researchers and biochemistry professionals have shaped our understanding of what users actually need. N-Methyl-L-Histidine Methyl Ester is not just another derivative in the long list of amino acid esters. It brings a distinctive profile suited for advanced peptide synthesis, for use as biochemical probes, and exploration in pharmacological studies. Once an uncommon specialty, requests for this ester now come in from biotech, pharmaceutical labs, and academic research groups across several continents.
The addition of an N-methyl group to the imidazole ring changes both the electronic properties and the steric environment. That often translates into reduced reactivity toward certain enzymes and alters hydrogen bonding in peptide backbones. Over time, researchers searching for new peptide analogues to tackle stability issues in protease-rich environments have reached out, reporting that methylation can enhance target selectivity or metabolic resistance.
We learned that subtle impurities can derail a project—even in small-scale screenings—so our quality controls go beyond purity percentages on paper. For NMHE-2172, a batch never leaves the plant without passing detailed HPLC and NMR checks, with chiral purity data double-verified against reference standards. Deciding on chromatography parameters took more trial than theory, as standard reversed-phase columns sometimes failed to show trace contaminants, prompting us to develop custom gradients and longer detection windows. Not every manufacturer commits to that level of scrutiny, but project failures in early years taught us that even a few tenths of a percent can mislead downstream users, sparking wasted effort in otherwise promising studies.
Our N-Methyl-L-Histidine Methyl Ester presents as a fine, off-white powder, with a mild odor typical of histidine derivatives. Moisture content stays below 0.5 percent, confirmed by Karl Fischer titration, which helps prevent caking and ensures consistent dosing during formulation. The melting point ranges tightly within single degrees at 154–156°C, a narrow window that reflects both careful synthesis and gentle handling post-crystallization. These properties matter because lumps, yellowing, or odd odors signal problems upstream—signs that someone rushed a step, missed a filtration, or exposed the product to stray acids.
Questions often arise from researchers about the difference between N-Methyl-L-Histidine Methyl Ester and more common esters, like plain histidine methyl ester. From my own work with both, the methylated version handles better in reactions that involve N-protection or situations where the imidazole ring can otherwise interfere. Removing a reactive hydrogen at the nitrogen position changes compatibility with protecting groups, shifts solubility slightly downward in aqueous buffers, and alters UV absorbance in detection assays. In practice, product loss drops during work-ups due to lower water solubility, and the yield in solid-phase peptide synthesis usually improves through tighter selectivity.
Some users initially think the differences are subtle, but feedback shows the downstream impact compounds. Histidine methyl ester, for example, remains open to modification along both the amine and carboxylic ends, making it ideal for very flexible peptide assembly or chelation strategies. Once a methyl group is installed at the N, reaction routes close off, but what remains is more predictable, and side reactions fall away. Researchers focusing on next-generation peptide drugs often describe their preference for the N-methyl ether as stemming from the way it streamlines purification steps and sharpens assay results. Experienced peptide chemists rarely go back once they see this effect firsthand.
A lab’s daily work rhythm does not wait for resupply or tolerate products that break down in storage. We offer N-Methyl-L-Histidine Methyl Ester in quantities from 25-gram vials to multi-kilo drums, each under tightly controlled conditions. On the shop floor, we learned the hard way that sweating inventory in ordinary storerooms brings hydrolysis or degradation. Now, every package ships under nitrogen, in moisture-impermeable containers, kept at 2–8°C until the moment it leaves our warehouse. That may seem excessive, but one spoiled drum can jeopardize a six-month research timeline.
We have replaced old packaging with high-density polyethylene and glass, switching seals after consultations with long-term partners who reported even microleaks impacting their analytical controls. The cost of robust packaging usually pays for itself. The difference between us and bulk resellers comes out in stories of labs able to store material for extended periods, trusting it stays chemically inert, whether opened a week or a year after it arrives.
In peptide synthesis labs, NMHE-2172 frequently forms part of protected fragments built for solid-phase approaches. The reduced nucleophilicity of the N-methyl imidazole lets builders push for longer chain lengths or perform post-assembly modifications without running into racemization or unwanted hydrolysis. I recall a client running into repeated losses with non-methylated versions until switching; yields for their seven-residue chain jumped 18 percent, and product spot tests cleaned up on HPLC. Minor process tweaks—raising the coupling agent strength or adjusting the deprotection protocol—also stuck better with the more stable N-methylated core.
Some groups use NMHE-2172 as a reference marker for high-performance liquid chromatography and mass spec, given its characteristic ionization pattern and strong UV response. Feedback from academic groups running enzyme assays has pointed to the stability of our material when incubated with various proteases, allowing more precise readings in kinetic studies. The unique methyl group on the nitrogen also appears to block certain unwanted enzyme-substrate interactions, resulting in cleaner, more interpretable results across hours-long reaction timelines.
Applications stretch into drug design, especially in analogues where scientists want to mimic histidine’s aromaticity but avoid rapid metabolic breakdown. Peptide and peptidomimetic projects seeking enzyme-resistant modifications find NMHE-2172 attractive. Groups exploring histamine pathway antagonists often find low cross-reactivity during screening, allowing more accurate mapping of binding sites or modification points.
Our plant never pretended to know more than those at the bench. Consultation with users has taught us that even a few missed details—slightly off pH, inconsistent moisture, or a few stubborn colored particles—can set projects back weeks. We heard stories of clogging in automated peptide synthesizers traced to faintly larger crystals and learned to adjust our crystallization step to bring size down without seeding dust that can turn into larger conglomerates. Each change in protocol carried through to cleaner runs and higher customer satisfaction.
On one occasion, a pharmaceutical team hit a snag with a batch that developed micro-clumps in their robotic feeders. Their experience pointed to trace levels of residual solvents we had missed, prompting us to extend our vacuum drying protocols even further and roll out solvent-specific GC checks. That single feedback round rippled into subsequent cycles and remains part of every batch release. No marketing claim carries the weight of direct field feedback, and our ongoing adjustments stem just as much from challenge as from success.
Installing the N-methyl group into the imidazole system delivers more than a molecular tweak. We’ve seen firsthand how it shields the molecule from unwanted enzymatic attack. Enzyme degradation, especially by nonspecific proteases or amidases, slows down, which makes NMHE-2172 valuable in the preparation of peptides meant to last longer in biological assays or therapeutic situations. The methyl group also suppresses tautomeric shuffling—a subtlety easily overlooked, but essential for applications where imidazole’s electronic behavior matters.
Laboratory feedback often touches on improved signal-to-noise ratios in protein interaction studies. Mass spectrometric data typically show sharper, more predictable peaks, simplifying quantitation and supporting better reproducibility. Peptide fragments containing NMHE-2172 tend to survive both harsher synthetic conditions and prolonged storage, opening doors for more extended biological testing cycles without repeated formulation.
Every chemical plant must strike a balance between high-yield processes and environmental stewardship. For us, that means refining our process routes to use as little hazardous solvent as possible, reusing non-reactive washes, and capturing vapors for appropriate treatment. The synthesis leading to NMHE-2172, especially in the methylation stages, involves handling methylating agents and strong bases. Years ago, we experienced problems with solvent waste that demanded additional treatment infrastructure. Now, most mother liquors pass through a dedicated neutralization and recycling loop, shrinking our waste footprint to less than half of what we saw before those improvements.
Handling guidance learned at the bench feeds into all our product documentation. N-Methyl-L-Histidine Methyl Ester shows low acute toxicity but, like many amino acid derivatives, carries risks of irritation if inhaled or contacted by skin. We don’t see product loss from improper storage now that every container leaves with clear-use labels, water-resistant seals, and secondary containment. Operational safety drills, honest incident reviews, and site visits from users continue to point out practices and small fixes that make all the difference. Taking the chance to talk with plant visitors refreshed our view—no pair of eyes sees the same process the same way, and each perspective tightens our practices.
Manufacturers sometimes face questions about cost—histidine methyl esters without N-methyl come cheaper, and many resellers offer off-grid material for less. The difference in price often comes down to the number of synthesis and purification steps, quality of starting material, and thoroughness of analytical checks. Cheaper products may carry trace by-products, less batch-to-batch stability, and packing protocols that allow air, moisture, or solvent ingress over time. In the end, a failed experiment costs more than the difference per kilogram, especially when biological data or intellectual property depends on reliable, reproducible performance.
We have received samples from researchers who tried to save on costs, only to ask us to analyze problems with their results. Trace alkali, tiny amounts of unreacted histidine, and off-spec methyl groups have all surfaced in those cases. Sorting those issues required targeted testing that most bulk resellers skip. That cycle of disappointment rarely recurs after users see how much smoother their syntheses and analyses go using high-purity, well-stored batches.
Shipping a specialty compound like NMHE-2172 involves more than just clean flasks and final weigh-outs. We modified our site workflow so that every order triggers a multi-step verification—locking in handling at cold temperature, running both immediate release and retention sample tests, and updating traceability logs to meet regulatory checks. On the floor, our team learned to spot issues by smell and texture long before an assay confirms it. This human touch, backed by years of hands-on experience, reinforces a level of trust in each batch.
Over years of batches, we saw that maintaining high purity also relies on small environmental factors. Even the humidity of a packaging room or the time spent between batch crystallization and packing can impact how well the powder resists clumping or yellowing in storage. The experience of seeing a visually flawless batch degrade due to ten extra minutes on a bench led us to limit handling times, add desiccant steps, and train teams to treat each packing run as critically as synthesis. Most users see only the lab results, but that cumulative effect of behind-the-scenes process control means less troubleshooting once the product lands on their shelves.
Feedback from cutting-edge research drives us to refine both process and support. One pharmaceutical group, working on enzyme-resistant peptide analogues, reported a doubling in candidate molecule lifetime in simulated biological fluids when switching from unmethylated products. Another team focused on biosensor research saw improved baselines when using our NMHE-2172 as a reference standard in calibration curves, enabling parts-per-billion readings that earlier resulted in inconsistent peaks.
University collaborators exploring modifications in the histamine signaling pathway have shared findings around sharper differentiation in receptor binding experiments, reducing cross-reactivity and broadening their assay toolkit. For them, what began as a simple supplier search matured into an ongoing research partnership, with our technical team advising on process tweaks and helping interpret unexpected analytical findings. This ongoing collaboration brings us closer to the research bench, and connects each batch produced with tangible scientific advances—not just left on a material shelf.
In academia, one graduate group relayed that previously intractable coupling reactions worked smoothly once N-methylation blocked unwanted hydrogen bonding from interfering. Their analogues remained traceable throughout up to four synthetic steps deeper than standard methyl esters, allowing experiments once ruled out as impractical cost- or time-wise.
From process design to packaging and final dispatch, constant improvement forms the core of how we operate. Each failed batch, even just off-color or slightly wet, prompts a review. Sometimes lessons come from outside: a visiting scientist—while reviewing crystallization at our pilot reactor—spotted a vent angle that led to micro-exposures of newly crystalized powder, prompting us to recalibrate shield placement. In other instances, field technicians highlighted that introducing color-change desiccants in every drum yielded instant cross-checks for any breach of seal integrity.
All these seemingly small adjustments build a better, sturdier supply chain and reinforce reliability from batch one through the fiftieth. Regular feedback rounds, both in-person and virtual, drive the process forward. When users hit walls—whether in solubility, reactivity, or handling—sharing those roadblocks helps us craft the next improvement. Rather than see a product as “finished,” we treat every user’s feedback as a springboard for the next production cycle.
The chemical landscape is always shifting. More researchers are moving toward modified peptides for improved delivery, resistance to degradation, and tailored bioactivity. N-Methyl-L-Histidine Methyl Ester has found its place in a growing toolkit of designer building blocks, used not only for specialized peptide synthesis but also in defining new standards for analytical assays and enzyme studies. Patents referencing methylated histidine derivatives have grown, and the range of journals citing this compound’s role in stability studies and molecular recognition work continues to expand.
We see that as both an endorsement of the work behind each batch and a responsibility to keep pace with new needs as they arise. Building strong relationships with users feeds back into refining not just production, but also making it easier to use the compound safely, efficiently, and productively in increasingly demanding laboratories.
Producing N-Methyl-L-Histidine Methyl Ester is more than just chemistry—it’s an ongoing commitment to serving the needs of a research community that relies on every molecule to deliver, batch after batch. Listening to the problems customers face, learning from every slip, and owning the craftsmanship behind every quality control detail—that’s what turns a specialized ester into a trusted laboratory tool. For us, the results come not only in high-purity percentages but in stories of successful projects, fewer failed experiments, and genuine scientific progress built on a foundation of reliable supply and shared expertise.